SBRT + Ipilimumab/Nivolumab clinical trials

SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer

This study looks at combining a specific type of radiation, SBRT, with two immunotherapy drugs, ipilimumab and nivolumab, for advanced kidney cancer. It compares giving SBRT with these drugs versus giving the drugs alone, for patients who can't have surgery.